StockData

Rafael Holdings, Inc. (RFL) stock

RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 5/30
$0.91−0.06 (-5.84%)

Close on Nov 17, 2026Market cap $47.67MP/E –Yield –

Rafael cash

Cash and short-term investments held at the end of each period.

Rafael's cash was $22.10M at Jul 31, 2026. For fiscal 2026 it was $22.10M, down 58.1% from the year before. Over ten years it grew 25.2% a year on average. The highest annual figure on record is $79.21M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2026Jul 31, 2026$22.10M-58.1%
FY2025Jul 31, 2025$52.77M-20.0%
FY2024Jul 31, 2024$65.94M-16.8%
FY2023Jul 31, 2023$79.21M+25.3%
FY2022Jul 31, 2022$63.24M+391.9%
FY2021Jul 31, 2021$12.85M+107.1%
FY2020Jul 31, 2020$6.21M-48.4%
FY2019Jul 31, 2019$12.02M-70.3%
FY2018Jul 31, 2018$40.50M+244.5%
FY2017Jul 31, 2017$11.76M+402.6%
FY2016Jul 31, 2016$2.34M-58.6%
FY2015Jul 31, 2015$5.65M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jul 31, 2026$22.10M-58.1%
Q3 FY2026CQ1 2026Apr 30, 2026$30.50M-42.2%
Q2 FY2026CQ4 2025Jan 31, 2026$37.78M-21.8%
Q1 FY2026CQ3 2025Oct 31, 2025$45.54M-16.1%
Q4 FY2025CQ2 2025Jul 31, 2025$52.77M-20.0%
Q3 FY2025CQ1 2025Apr 30, 2025$52.77M-27.1%
Q2 FY2025CQ4 2024Jan 31, 2025$48.32M-32.6%
Q1 FY2025CQ3 2024Oct 31, 2024$54.30M+311.4%
Q4 FY2024CQ2 2024Jul 31, 2024$65.94M-16.8%
Q3 FY2024CQ1 2024Apr 30, 2024$72.38M-12.2%
Q2 FY2024CQ4 2023Jan 31, 2024$71.72M-19.3%
Q1 FY2024CQ3 2023Oct 31, 2023$13.20M-85.9%
Q4 FY2023CQ2 2023Jul 31, 2023$79.21M+25.3%
Q3 FY2023CQ1 2023Apr 30, 2023$82.40M+38.8%
Q2 FY2023CQ4 2022Jan 31, 2023$88.87M+26.9%
Q1 FY2023CQ3 2022Oct 31, 2022$93.85M+29.6%
Q4 FY2022CQ2 2022Jul 31, 2022$63.24M+391.9%
Q3 FY2022CQ1 2022Apr 30, 2022$59.37M+1168.9%
Q2 FY2022CQ4 2021Jan 31, 2022$70.03M+1050.6%
Q1 FY2022CQ3 2021Oct 31, 2021$72.39M+901.1%
Q4 FY2021CQ2 2021Jul 31, 2021$12.85M+107.1%
Q3 FY2021CQ1 2021Apr 30, 2021$4.68M-44.5%
Q2 FY2021CQ4 2020Jan 31, 2021$6.09M-36.1%
Q1 FY2021CQ3 2020Oct 31, 2020$7.23M-32.9%
Q4 FY2020CQ2 2020Jul 31, 2020$6.21M-48.4%
Q3 FY2020CQ1 2020Apr 30, 2020$8.43M-35.0%
Q2 FY2020CQ4 2019Jan 31, 2020$9.52M-35.5%
Q1 FY2020CQ3 2019Oct 31, 2019$10.77M-64.3%
Q4 FY2019CQ2 2019Jul 31, 2019$12.02M-70.3%
Q3 FY2019CQ1 2019Apr 30, 2019$12.97M-68.8%
Q2 FY2019CQ4 2018Jan 31, 2019$14.77M+23.0%
Q1 FY2019CQ3 2018Oct 31, 2018$30.15M+161.7%
Q4 FY2018CQ2 2018Jul 31, 2018$40.50M+244.5%
Q3 FY2018CQ1 2018Apr 30, 2018$41.55M+254.2%
Q2 FY2018CQ4 2017Jan 31, 2018$12.01M+1.2%
Q1 FY2018CQ3 2017Oct 31, 2017$11.52M+392.5%
Q4 FY2017CQ2 2017Jul 31, 2017$11.76M–
Q3 FY2017CQ1 2017Apr 30, 2017$11.73M–
Q2 FY2017CQ4 2016Jan 31, 2017$11.86M–
Q4 FY2016CQ2 2016Jul 31, 2016$2.34M–

More Rafael figures

See a number that looks wrong?